← Leaderboards
Ruchira Singh
University Of Rochester
$7,225,302
Attributed
$8,632,208
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,632,208 · 5
By mechanism
R01$8,215,638 · 4
R21$416,570 · 1
Top collaborators
- Danielle S. Benoit5 shared
- Vera L Bonilha1 shared
Most similar at University Of Rochester
Same institution · by research overlap
- David A Pearce$11,215,112
- Erika Augustine$6,110,416
- Heather Adams$639,425
- Jianhui Zhong$3,235,819
- Kuan Hong Wang$5,861,974
Others in their field
Other Emerging Leaders on “Pathology”
- Ted Ross · University Of Georgia$68,763,143
- Dale Sandler · Social And Scientific Systems, Inc.$59,740,435
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
Research focus
PathologyInduced Pluripotent Stem CellStructure Of Retinal Pigment EpitheliumFunctional DisorderMediatingImpairmentDepositionIn VitroPharmacotherapyAge Related Macular DegenerationComplexLinkMatrix MetalloproteinasesMolecularMutationExperimental StudyIn VivoPhenotypePathologicChoroidal NeovascularizationDrusenRetinaHomeostasisAtrophic
Grant awards (19)
Investigating the role of PLA2G2A/sPLA2-IIA in macular degeneration$658,889
R01 · FY2025 · EY · contact PI
Delineating the role of TIMP3 in macular degeneration$458,738
R01 · FY2025 · EY · contact PI
Using hiPSCs to develop physiologically-relevant outer retina tissue mimetics$588,670
R01 · FY2024 · EY · contact PI
Delineating the role of TIMP3 in macular degeneration$490,475
R01 · FY2024 · EY · contact PI
Using hiPSCs to develop physiologically-relevant outer retina tissue mimetics$622,940
R01 · FY2023 · EY · contact PI
Delineating the role of TIMP3 in macular degeneration$490,475
R01 · FY2023 · EY · contact PI
Using hiPSCs to develop physiologically-relevant outer retina tissue mimetics$526,743
R01 · FY2022 · EY · contact PI
Determining the role of CLN3 in the eye$458,180
R01 · FY2022 · EY · contact PI
Delineating the role of TIMP3 in macular degeneration$454,890
R01 · FY2022 · EY · contact PI
Determining the role of CLN3 in the eye$490,935
R01 · FY2021 · EY · contact PI
Delineating the role of TIMP3 in macular degeneration$373,450
R01 · FY2021 · EY · contact PI
hiPSC-derived tissue mimetics of the retina blood barrier$224,070
R21 · FY2021 · EY
Determining the role of CLN3 in the eye$505,390
R01 · FY2020 · EY · contact PI
Delineating the role of TIMP3 in macular degeneration$385,675
R01 · FY2020 · EY · contact PI
hiPSC-derived tissue mimetics of the retina blood barrier$192,500
R21 · FY2020 · EY
Determining the role of CLN3 in the eye$525,938
R01 · FY2019 · EY · contact PI
Delineating the role of TIMP3 in macular degeneration$385,675
R01 · FY2019 · EY · contact PI
Delineating the role of TIMP3 in macular degeneration$413,575
R01 · FY2018 · EY · contact PI
Delineating the role of TIMP3 in macular degeneration$385,000
R01 · FY2017 · EY · contact PI